Eric Burak
2020
In 2020, Eric Burak earned a total compensation of $1.8M as Chief Scientific Officer at Fusion Pharmaceuticals, a 277% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,902 |
|---|---|
| Option Awards | $1,221,626 |
| Salary | $388,277 |
| Other | $25,604 |
| Total | $1,822,409 |
Burak received $1.2M in option awards, accounting for 67% of the total pay in 2020.
Burak also received $186.9K in non-equity incentive plan, $388.3K in salary and $25.6K in other compensation.
Rankings
In 2020, Eric Burak's compensation ranked 5,950th out of 13,090 executives tracked by ExecPay. In other words, Burak earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,950 out of 13,090 | 55th |
Division Manufacturing | 2,448 out of 5,620 | 56th |
Major group Chemicals And Allied Products | 978 out of 2,253 | 57th |
Industry group Drugs | 846 out of 1,953 | 57th |
Industry Biological Products, Except Diagnostic Substances | 207 out of 411 | 50th |
Source: SEC filing on April 27, 2021.
Burak's colleagues
We found three more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2020.